Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease,
Sunoco LP Reports Fourth Quarter and Record Full Year 2024 Financial and Operating Results
Delivers record full-year 2024 financial and operating results -- Net income of $874 million -- Adjusted EBITDA(1), excluding one-time transaction-related expenses(2), of $1.56 billion -- Fuel volume of 8.
Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer ...
12don MSN
The U.S. economic outlook has become more cloudy, however. Trump has promised to cut taxes and ease regulations on business, ...
Adjusted net operating income from business segments was: $4,992 million in the fourth quarter 2024 versus $4,635 million in the third quarter 2024, mainly due to increases in hydrocarbon ...
Good day, ladies and gentlemen, and welcome to the Medpace Fourth Quarter and Full-Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' ...
Q4 2024 Earnings Call Transcript February 10, 2025 Lattice Semiconductor Corporation reports earnings inline with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback